CORE LABORATORIES INC.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $124.6M | $121.8M | $138.3M | $134.5M | $130.2M | $123.6M | $129.2M | $134.4M |
| Cost of Revenue | $101.4M | $102.1M | $109.5M | $104.9M | $103.7M | $99.5M | $106.2M | $106.8M |
| Gross Profit | $23.2M | $19.7M | $28.7M | $29.6M | $26.5M | $24.1M | $23.0M | $27.6M |
| Gross Margin | 18.6% | 16.2% | 20.8% | 22.0% | 20.3% | 19.5% | 17.8% | 20.5% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $11.0M | $14.7M | $10.6M | $10.7M | $10.5M | $13.6M | $9.1M | $8.6M |
| Operating Income | $9.2M | $1.9M | $15.8M | $20.9M | $15.3M | $4.4M | $14.2M | $19.8M |
| Operating Margin | 7.3% | 1.5% | 11.5% | 15.6% | 11.7% | 3.6% | 11.0% | 14.7% |
| Interest Expense | $2.8M | $2.9M | $2.6M | $2.7M | $2.7M | $2.6M | $2.6M | $3.1M |
| Pretax Income | $6.3M | $-1.0M | $13.2M | $18.3M | $12.6M | $1.8M | $11.5M | $16.7M |
| Income Tax Expense | $507.0K | $-251.0K | $8.1M | $3.8M | $1.9M | $1.7M | $4.1M | $4.7M |
| Net Income | $6.0M | $-789.0K | $4.9M | $14.2M | $10.6M | $-154.0K | $7.4M | $11.7M |
| Net Margin | 4.8% | -0.6% | 3.6% | 10.6% | 8.2% | -0.1% | 5.7% | 8.7% |
| EPS (Basic) | $0.13 | $-0.02 | $0.10 | $0.31 | $0.23 | $0.00 | $0.16 | $0.25 |
| EPS (Diluted) | $0.13 | $-0.02 | $0.11 | $0.30 | $0.22 | $0.00 | $0.15 | $0.25 |
| Shares Outstanding (Basic) | 46.0M | 46.1M | 46.4M | 46.3M | 46.6M | 46.8M | 46.9M | 46.9M |
| Shares Outstanding (Diluted) | 46.9M | 46.1M | 47.0M | 47.1M | 47.4M | 46.8M | 47.7M | 47.8M |
| Dividends Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |